Celldex Therapeutics, Inc (CLDX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CLDX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Wellington Management | 9,543,671 | $355M | INCREASED |
| BlackRock | 7,002,530 | $261M | INCREASED |
| Kynam Capital Management | 5,322,908 | $198M | DECREASED |
| Vanguard | 4,984,374 | $185M | INCREASED |
| T. Rowe Price | 4,685,223 | $174M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Harry Penner JR (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Herbert J Conrad (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| James J Marino (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Keith L Brownlie (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Cheryl Cohen (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
Full institutional holdings, insider history, and congressional trades for Celldex Therapeutics, Inc on SentiSense.